What is CV Sciences?
Established in 2010 and headquartered in San Diego, California, CV Sciences is structured around two primary divisions: pharmaceuticals and consumer products. The pharmaceutical arm is dedicated to developing synthetically formulated cannabidiol (CBD) based medicines, with a focus on obtaining U.S. Food and Drug Administration (FDA) approval for drugs targeting specific indications. Concurrently, the consumer products division offers botanical-based CBD products aimed at enhancing consumer quality of life. This dual approach positions CV Sciences within the burgeoning health and wellness market, leveraging scientific rigor for its pharmaceutical endeavors and consumer-centric innovation for its product lines.
How much funding has CV Sciences raised?
CV Sciences has raised a total of $15.1M across 4 funding rounds:
Debt
$2M
Debt
$2M
Other Financing Round
$10M
Debt
$1.1M
Debt (2016): $2M, investors not publicly disclosed
Debt (2020): $2M led by PPP
Other Financing Round (2020): $10M supported by Tumim Stone Capital
Debt (2021): $1.1M, investors not publicly disclosed
Key Investors in CV Sciences
Tumim Stone Capital
Tumim Stone Capital is an investor that participated in a significant financing round for CV Sciences. Their specific investment focus is not detailed, but their involvement suggests a strategic interest in the company's growth.
PPP
Public-Private Partnership
What's next for CV Sciences?
The recent major strategic investment, alongside the company's substantial total funding of $15.1M, suggests CV Sciences is poised for significant scaling and advancement, particularly within its pharmaceutical development pipeline. This capital infusion is likely to accelerate the pursuit of FDA approval for its CBD-based drug candidates and bolster the expansion of its consumer product offerings. The company's strategic financing history indicates a deliberate approach to growth, and this latest backing will be critical in navigating the complex regulatory landscape and competitive market dynamics in both the pharmaceutical and consumer wellness sectors.
See full CV Sciences company page
